An important feature of cancer glucose metabolism is the upregulation of glycolysis, which is manifested by an increase in glucose uptake and glycolytic metabolites. Detecting the production of glycolytic metabolites can understand the metabolic changes at each step in the glycolysis process of cancer cells, and help to find clinical diagnostic markers for potential targets of cancer therapy. CD BioGlyco can provide detection services for metabolites in the whole process of glycolysis from glucose uptake to lactate production.
Based on our MOPCGM platform, we can provide liquid chromatography detection of all metabolites in the glycolytic metabolic pathway.
We provide detection of single metabolites in the glycolytic pathway. The specific metabolites detected are as follows, including but not limited to:
CD BioGlyco provides liquid chromatography analysis of all metabolites in the glycolytic pathway of cancer cells and colorimetric and fluorescence detection of single products. Our experienced teams of scientists, researchers, and technicians provide fast turnaround, high-quality services at competitive prices for worldwide customers. Our customers have direct access to our staff and prompt feedback on their inquiries. If you are interested in our services, please contact us for more details.